Companies
J. Craig Venter Institute
the J. Craig Venter Institute remains the world centre for minimal-genome research, having built the JCVI-syn1.0 to JCVI-syn3.5 series and continuing to assign function to the "dark genes" still uncharacterised in the minimal genome.
- Country
- United States
Coverage
| CN | EU | US | |
|---|---|---|---|
| genome-engineering | ✓ | ✓ | ✓ |
Regulatorsepaefsanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Affiliation | not-for-profit genomics research institute (501(c)(3) organization) | jcvi.org |
| Research focus | human genomics, microbiome, bioinformatics, synthetic biology, infectious disease, and microbial/environmental genomics | jcvi.org |
| Facility | La Jolla, California and Rockville, Maryland | jcvi.org |
| Grant | $2.4M NSF grant, $5M NSF grant (CIRCLE), $5.7M NIH grant, $5M Roddenberry Foundation grant, $43M NIAID contract, $200k St. Baldrick's Foundation grant, $4.7M NIDA grant | jcvi.org |
| Publications | synthetic minimal bacterial cell (JCVI-syn1.0 to JCVI-syn3.5 series) and genomic research publications in top-tier journals | jcvi.org · dongascience.com |
| Principal staff | J. Craig Venter (Founder, CEO, Chair), Anders Dale (President), John Glass (Professor/Director), Robert Friedman (Deputy Director) | jcvi.org |
| Headcount | approximately 120 scientists and staff | jcvi.org |
Independent sources: dongascience.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Minimal genomes & synthetic cells | genome-engineering | High | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.